Multimodal Liver-Directed Management of Neuroendocrine Hepatic Metastases

Table 1

Suggested eligibility criteria for resection of NET liver metastases.

---

No miliary disease on preoperative liver imaging(MRI or multidetector CT)

---

Little to no extrahepatic disease on preoperative nuclear medicine studies

(^18FF-DOPA PET preferred over octreotide scintigraphy for carcinoid)

---

Well- or moderately differentiated neuroendocrine carcinoma

(Ki-67 <20% and ideally, <15%)

---

Projected volume of residual functional liver >30%

---

No tumor necrosis

---